Tag: US FDA

FDA Approves Olumiant for Adolescents with Severe Alopecia Areata

FDA approves Olumiant (baricitinib) for patients aged 12 and older with severe…

FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy

The US FDA has granted traditional approval to Novartis' Fabhalta® (iptacopan), the…